This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
 
Shire and AbbVie in $54B Deal Talks Following Sweetened Bid

Dublin-based drugs maker Shire said Monday it had entered "detailed discussions" with AbbVie about a $54 billion takeover proposal.

Citigroup to Pay $7 Billion in Settlement Over Mortgage Securities

Citigroup (C) has agreed to pay $7 billion to settle investigations into its sale of mortgage securities leading up to the financial crisis.

Apple Upgraded; Bearish Calls on eBay, Wells Fargo

In Monday's Analysts' Actions, Apple gets an upgrade at Barclays, Pacific Crest makes a bearish call on eBay and JPMorgan lowers its price target on Wells Fargo.

Cramer: GE Needs a Boost to Its Dividend, Target is Going Higher

Jim Cramer answers viewers' Twitter questions from the floor of the New York Stock Exchange.

Boeing, Airbus Close in on Multi-Million Dollar Deals With BOC Aviation

Singapore-based aircraft leasing company BOC Aviation, a Bank of China offshoot, is reportedly close to cementing deals to purchase jet models from both Airbus and Boeing.

Real Money Previews

Cramer: Digging Under the Whiting-Kodiak Tie-Up

It wouldn't surprise me if Whiting has been in contact with its own buyer.

Sozzi: A Steaming Pile of Retail

Those same-store-sales numbers sure were ugly.

Skeleton in the EU Banking Closet; Parsing Jobless Claims Data: Best of Kass

In highlights from his trading diary of the past week, Doug Kass writes about a threat to the European financial community and jobless claims.

Mad Money Recap

'Mad Money' Lightning Round: Aerospace Is Terrific

Cramer likes Southern Company and wants to stick with Core Labs despite its disappointing quarter.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

5 Hated Earnings Stocks You Should Love

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

5 Rocket Stocks to Buy for Summer Gains

These stocks have both short-term gain catalysts and longer-term growth potential.

4 Stocks Spiking on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

5 Stocks Breaking Out With Big Volume

These stocks rising on unusual volume are within range of triggering breakout trades.

5 Stocks Ready for Breakouts

These stocks look poised to break out and trade higher from current levels.

MainStreet

Mortgage Rates Could Ruin Summer Home-Sales Hopes

June and July are usually the busiest months of the year for real estate agents, but mortgage applications and loan size are slumping.

Debt Is Dragging Down the American Dream

If retiring comfortably seems a modest enough goal for Americans, pity the quarter of the country that just wants to get out of debt.

10 Best Used Luxury Cars Under $30,000

A certified pre-owned luxury vehicle gives a buyer all of the comfort with little of the immediate depreciation. It's how you get vehicles from Acura to Mercedes on the cheap.

5 Things to Do on Fridays to Make Mondays a Breeze

Mondays at the office are never fun, but you can plan ahead and set yourself up for a successful, worry-free start to the week.

3 Principles That Make It Easier to Become an Entrepreneurship

More entrepreneurship ideas, resources, tools and options than ever before are at your fingertips for free. But before you dive in, check out these tips.

Biotech

Investor Believes Roche Buys Exelixis for Skin-Cancer Drug

Healthcare investor David Miller believes Roche will likely acquire Exelixis in order to capture the full economics of the cancer drug cobimetinib.

Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Roche, Exelixis Skin Cancer Drug Delays Tumor Progression

Roche intends to seek U.S. approval for cobimetinib later this year.

Beyond Wall St.

Deal News

Shire and AbbVie in $54B Deal Talks Following Sweetened Bid

Dublin-based drugs maker Shire said Monday it had entered "detailed discussions" with AbbVie about a $54 billion takeover proposal.

Cramer: Digging Under the Whiting-Kodiak Tie-Up

It wouldn't surprise me if Whiting has been in contact with its own buyer.

Mylan Gets Abbott Generics Business in $5.3B Deal

Mylan said Monday it has a deal in place to acquire the developed markets generic drugs business of Abbott Laboratories in a stock deal valued at $5.3 billion.

TheStreetTV
Spin Space

Jim Cramer

Cramer: Digging Under the Whiting-Kodiak Tie-Up

It wouldn't surprise me if Whiting has been in contact with its own buyer.

Herb Greenberg

Greenberg: Where are the Cops?

The halt in CYNK Technology points up the inaction on Lumber Liquidators and the heavy put options trading on other stocks.

Stephanie Link

Link: Waddell & Reed Offers Growth at a Nice Price

This asset manager's stock pullback looks like an opportunity.

Chris Ciaccia

Apple's Almost Back: A Chart You Should See

Apple's recovery from the fall in late 2012 and most of 2013 is nearly complete, as the company gets ready to launch new products later this year.

Adam Feuerstein

Investor Believes Roche Buys Exelixis for Skin-Cancer Drug

Healthcare investor David Miller believes Roche will likely acquire Exelixis in order to capture the full economics of the cancer drug cobimetinib.

Laurie Kulikowski

Lululemon Jumps on Report Wilson Talking to Private Equity

Lululemon Athletica was rising 2.1% to $42.29 after The Wall Street Journal reported that founder Dennis "Chip" Wilson was talking to PE firms about taking the yoga apparel maker p...

Dan Freed

Barclays Charged With Fraud Over 'Dark Pool'

Barclays Capital committed fraud tied to a private, internal stock trading platform known as a 'dark pool,' according to charges filed Wednesday by New York Attorney General Eric S...

Rocco Pendola

Apple Well On Its Way to Absolutely Devastating Microsoft

Recent data suggests a scary conclusion for Microsoft -- business customers might be moving away from Windows/Office pursuant to employee demand.

Ted Reed

Boeing 747 Fades Out but Lufthansa Flies a Fresh One to JFK

Boeing's 747, a radical innovation when it was introduced in 1970, is on the way out. But Lufthansa remains committed to the newest versions of the airplane.

Leon Lazaroff

Aereo Loses as Supreme Court Rules Service Violates Copyright Law

Aereo's future was put in doubt as the Supreme Court ruled that the video-streaming service violates U.S. copyright law.

Submit an article to us!
DOW 17,075.81 +132.00 0.78%
S&P 500 1,978.44 +10.87 0.55%
NASDAQ 4,444.5310 +29.0410 0.66%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs